S. 1094 (107th): Hematological Cancer Research Investment and Education Act of 2002
Jun 22, 2001
107th Congress, 2001–2002
Enacted — Signed by the President
on May 14, 2002
This bill was enacted after being signed by the President on May 14, 2002.
Senator from Texas
Read Text »
Last Updated: May 2, 2002
Length: 2 pages
About the bill
- Full Title
A bill to amend the Public Health Service Act to provide for research, information, and education with respect to blood cancer.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Jul 25, 2001
- What is a bill?
The “S.” in “S. 1094” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
6 cosponsors (5D, 1R) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 1094 — 107th Congress: Hematological Cancer Research Investment and Education Act of 2002. Retrieved from https://www.govtrack.us/congress/bills/107/s1094
“S. 1094 — 107th Congress: Hematological Cancer Research Investment and Education Act of 2002.” www.GovTrack.us. 2001. February 26, 2015 <https://www.govtrack.us/congress/bills/107/s1094>
|title=S. 1094 (107th)
|accessdate=February 26, 2015
|author=107th Congress (2001)
|date=June 22, 2001
|quote=Hematological Cancer Research Investment and Education Act of 2002